Fig. 6From: CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modificationVIRMA promotes ICC proliferation and metastasis in vivo, and is correlated with poor prognosis of ICC patients. Knockdown of VIRMA effectively inhibited ICC subcutaneous tumor growth in nude mice (n = 5). a Gross images of ICC subcutaneous tumor. b In vivo fluorescence imaging of nude mice bearing ICC tumors. c The tumors were extracted and weighed after 4 weeks. d The tumor volume was monitored every other day, and tumor growth curves were generated. e Representative images of IHC staining for VIRMA protein of 110 ICC tumor tissues and their adjacent normal epithelium tissues. Scale bars, 100 μm. f The protein expression level of VIRMA was analyzed in 110 ICC tissues and their paired normal epithelium tissues through IHC staining. g The protein expression level of VIRMA was analyzed in ICC tissues and normal epithelium tissues of the TCGA dataset. ***p = 2.21E − 07. The two-tailed t-test in paired samples. The box boundaries correspond to the first and third quartiles; whiskers extend to a maximum of 1.5 × the interquartile range. h, i Kaplan–Meier method with a two-tailed log-rank test was used to plot overall survival (h) and disease-free survival (i) curves in human ICC specimens (n = 110) with high and low VIRMA expression. The log-rank test was used to compare the survival rate. j H&E and IHC staining with an antibody specific for VIRMA, E-cadherin, N-cadherin, Vimentin, VEGF, Ki67 and Cyclin D1 in sections of tumors. *P < 0.05 **P < 0.01, ***P < 0.001Back to article page